GlassScriptPhysician profile
Samir K Gupta
NPI 1073542585
$8,877.46
in general payments reported to CMS, 2019-2025
23 companies · $268 in 2025
The $268 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,359 · 2022: $358 · 2023: $3,731 · 2024: $161 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $1,144 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $1,144.02 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,823.75 | 2021-2023 | Davinci Xi, Da Vinci Surgical System |
| Ethicon US, LLC | $256.04 | 2021-2024 | Vistaseal, Stratafix, Ethicon |
| Nevro Corp. | $100.72 | 2021 | |
| Bolton Medical INC | $89.92 | 2025 | Thoraflex Hybrid |
| Axsome Therapeutics, INC. | $53.18 | 2025 | Auvelity |
| Polynovo North America LLC | $51.52 | 2024-2025 | Novosorb Btm |
| Conmed Corporation | $50.00 | 2023 | Airseal |
| Innocoll Pharmaceuticals Limited | $48.63 | 2021 | |
| Medtronic, INC. | $44.71 | 2023 | Signia |
| Davol INC. | $33.07 | 2021 | |
| Abbvie INC. | $32.61 | 2022-2024 | |
| Depuy Synthes Sales INC. | $30.84 | 2022 | |
| Tela Bio, INC. | $30.76 | 2021 | |
| Baxter Healthcare | $30.63 | 2025 | Perclot |
| Takeda Pharmaceuticals U.S.A., INC. | $30.28 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25.80 | 2022 | |
| Innovation Technologies INC | $23.16 | 2025 | Irrisept |
| Csl Behring | $22.96 | 2022 | |
| Merck Sharp & Dohme LLC | $22.10 | 2025 | Keytruda, Lynparza |
| Pacira Pharmaceuticals Incorporated | $21.90 | 2024 | Exparel, Iovera |
| Zimmer Biomet Holdings, INC. | $20.88 | 2023 | Advantagerib |
| Reprise Biomedical, INC. | $19.21 | 2025 | Miro3d |
| W. L. Gore & Associates, INC. | $14.79 | 2025 | Gore Synecor Biomaterial |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.